TFX Stock Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
No risks detected for TFX from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$292.76|
|52 Week High||US$428.36|
|52 Week Low||US$256.77|
|1 Month Change||-13.03%|
|3 Month Change||-10.47%|
|1 Year Change||-25.61%|
|3 Year Change||-0.89%|
|5 Year Change||46.63%|
|Change since IPO||2,721.78%|
Recent News & Updates
Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Teleflex Incorporated ( NYSE:TFX ) received a lot of attention from a substantial price movement on the NYSE over the...
|TFX||US Medical Equipment||US Market|
Return vs Industry: TFX underperformed the US Medical Equipment industry which returned -15.1% over the past year.
Return vs Market: TFX underperformed the US Market which returned -10.8% over the past year.
|TFX Average Weekly Movement||5.1%|
|Medical Equipment Industry Average Movement||10.6%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.9%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: TFX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.
About the Company
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Fundamentals Summary
|TFX fundamental statistics|
Is TFX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TFX income statement (TTM)|
|Cost of Revenue||US$1.27b|
Last Reported Earnings
Mar 27, 2022
Next Earnings Date
|Earnings per share (EPS)||10.40|
|Net Profit Margin||17.31%|
How did TFX perform over the long term?See historical performance and comparison
0.5%Current Dividend Yield
Is Teleflex undervalued compared to its fair value and its price relative to the market?
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TFX ($292.76) is trading below our estimate of fair value ($458.61)
Significantly Below Fair Value: TFX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TFX is good value based on its PE Ratio (28.2x) compared to the US Medical Equipment industry average (35.1x).
PE vs Market: TFX is poor value based on its PE Ratio (28.2x) compared to the US market (15.5x).
Price to Earnings Growth Ratio
PEG Ratio: TFX is poor value based on its PEG Ratio (6.9x)
Price to Book Ratio
PB vs Industry: TFX is overvalued based on its PB Ratio (3.6x) compared to the US Medical Equipment industry average (2.5x).
How is Teleflex forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TFX's forecast earnings growth (4.1% per year) is above the savings rate (1.9%).
Earnings vs Market: TFX's earnings (4.1% per year) are forecast to grow slower than the US market (12.5% per year).
High Growth Earnings: TFX's earnings are forecast to grow, but not significantly.
Revenue vs Market: TFX's revenue (5.6% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: TFX's revenue (5.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TFX's Return on Equity is forecast to be low in 3 years time (13.7%).
How has Teleflex performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TFX has high quality earnings.
Growing Profit Margin: TFX's current net profit margins (17.3%) are higher than last year (11%).
Past Earnings Growth Analysis
Earnings Trend: TFX's earnings have grown significantly by 20.8% per year over the past 5 years.
Accelerating Growth: TFX's earnings growth over the past year (74%) exceeds its 5-year average (20.8% per year).
Earnings vs Industry: TFX earnings growth over the past year (74%) exceeded the Medical Equipment industry 16.7%.
Return on Equity
High ROE: TFX's Return on Equity (12.8%) is considered low.
How is Teleflex's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: TFX's short term assets ($1.5B) exceed its short term liabilities ($656.2M).
Long Term Liabilities: TFX's short term assets ($1.5B) do not cover its long term liabilities ($2.4B).
Debt to Equity History and Analysis
Debt Level: TFX's net debt to equity ratio (35.8%) is considered satisfactory.
Reducing Debt: TFX's debt to equity ratio has reduced from 91.7% to 48.8% over the past 5 years.
Debt Coverage: TFX's debt is well covered by operating cash flow (32.6%).
Interest Coverage: TFX's interest payments on its debt are well covered by EBIT (11.2x coverage).
What is Teleflex current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TFX's dividend (0.46%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: TFX's dividend (0.46%) is low compared to the top 25% of dividend payers in the US market (4.06%).
Stability and Growth of Payments
Stable Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: TFX is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: TFX is not paying a notable dividend for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Liam Kelly (54 yo)
Mr. Liam J. Kelly has been Chief Executive Officer at Teleflex Incorporated since January 01, 2018 and has been its Director since May 4, 2018. He serves as Independent Director of Enovis Corporation (form...
CEO Compensation Analysis
Compensation vs Market: Liam's total compensation ($USD8.67M) is below average for companies of similar size in the US market ($USD13.27M).
Compensation vs Earnings: Liam's compensation has increased by more than 20% in the past year.
Experienced Management: TFX's management team is seasoned and experienced (5 years average tenure).
Experienced Board: TFX's board of directors are considered experienced (5.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Teleflex Incorporated's employee growth, exchange listings and data sources
- Name: Teleflex Incorporated
- Ticker: TFX
- Exchange: NYSE
- Founded: 1943
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: US$13.195b
- Shares outstanding: 46.90m
- Website: https://www.teleflex.com
Number of Employees
- Teleflex Incorporated
- 550 East Swedesford Road
- Suite 400
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/17 00:00|
|End of Day Share Price||2022/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.